Clinica San Francesco
Garofalo Health Care S.p.A. is a leading private healthcare group in Italy, listed on the Euronext STAR segment of the Italian Stock Exchange. It operates through 37 healthcare facilities across 8 regions, offering a wide range of medical services with a focus on innovation, professionalism, and humanized care. The group emphasizes continuous training, scientific research, and modernization of healthcare infrastructure, with a mission to bring together health facilities of excellence and place patients at the center of the system. The company has a strong presence in the Italian healthcare sector, with consistent growth in revenue, strategic acquisitions, and active engagement in corporate governance and sustainability initiatives.
Industries
Nr. of Employees
medium (51-250)
Clinica San Francesco
Verona, Veneto, Italy, Europe
Services
Provision and management of inpatient, outpatient, surgical, diagnostic imaging, rehabilitation, cardiology, psychiatric and long-term care services through a network of accredited facilities across multiple regions.
Collaboration with national and international research institutions and universities on clinical research and staff continuous training across specialized medical areas.
Preparation, publication and maintenance of governance frameworks, internal procedures (insider/internal dealing, related‑party), codes of ethics, compliance models and whistleblowing procedures.
Formal ethical review of clinical protocols and research projects via institutional governance structures, including issuance of opinions on compliance with ethical principles prior to study initiation.
Support for preparation and coordination of research projects, promotion of multicentre collaboration, assistance with funding submissions and mapping of clinical research capabilities across the network.
Preparation and publication of consolidated and separate financial statements, non-financial statements, periodic reporting and prospectus/admission documentation for regulatory disclosure and investor communications.
Provision and management of inpatient, outpatient, surgical, diagnostic imaging, rehabilitation, cardiology, psychiatric and long-term care services through a network of accredited facilities across multiple regions.
Collaboration with national and international research institutions and universities on clinical research and staff continuous training across specialized medical areas.
Preparation, publication and maintenance of governance frameworks, internal procedures (insider/internal dealing, related‑party), codes of ethics, compliance models and whistleblowing procedures.
Formal ethical review of clinical protocols and research projects via institutional governance structures, including issuance of opinions on compliance with ethical principles prior to study initiation.
Support for preparation and coordination of research projects, promotion of multicentre collaboration, assistance with funding submissions and mapping of clinical research capabilities across the network.
Preparation and publication of consolidated and separate financial statements, non-financial statements, periodic reporting and prospectus/admission documentation for regulatory disclosure and investor communications.
Expertise Areas
- Corporate governance and board committee structuring
- Enterprise risk management and internal controls
- Regulatory financial reporting and investor communications
- Compliance for insider trading, internal dealing and anti-corruption
Key Technologies
- ESEF/XHTML and taxonomy-based financial reporting
- Secure whistleblowing and confidential reporting platforms
- Internal-dealing and insider register control systems
- KRI monitoring and risk dashboard systems
News & Updates
Shareholders' Meeting 2025
Various resolutions, reports, and documentation related to the Shareholders' Meeting scheduled for April 30, 2025.
2024 Corporate Governance and Ownership Structure Report
Report detailing the corporate governance and ownership structure for FY2024.
Financial Statements FY2024
Official financial statements for FY2024 presented at the Shareholders' Meeting.
Remuneration Policy 2024 and Compensation 2023
Details of the remuneration policy and compensation for FY2023 and FY2024.
Policy on Diversity of the Administrative and Control Bodies
The policy provides non-binding indications regarding gender, age, training, and professional background to ensure effective management and control bodies.
Corporate Governance System
The governance system is based on a traditional management and control model, with structures including the Board of Directors, Shareholders' Meeting, and Supervisory Bodies.
Shareholders' Meeting 2025
Various resolutions, reports, and documentation related to the Shareholders' Meeting scheduled for April 30, 2025.
2024 Corporate Governance and Ownership Structure Report
Report detailing the corporate governance and ownership structure for FY2024.
Financial Statements FY2024
Official financial statements for FY2024 presented at the Shareholders' Meeting.
Remuneration Policy 2024 and Compensation 2023
Details of the remuneration policy and compensation for FY2023 and FY2024.
Policy on Diversity of the Administrative and Control Bodies
The policy provides non-binding indications regarding gender, age, training, and professional background to ensure effective management and control bodies.
Corporate Governance System
The governance system is based on a traditional management and control model, with structures including the Board of Directors, Shareholders' Meeting, and Supervisory Bodies.